These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36287161)

  • 1. [Ocular hypertension after intravitreal injections].
    Erichev VP; Tarasenkov AO; Andreeva YS
    Vestn Oftalmol; 2022; 138(5. Vyp. 2):234-239. PubMed ID: 36287161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Sisk RA; Rusia D; Zamora BG; Kuley A; Toussaint BW
    Retina; 2019 Oct; 39(10):1959-1964. PubMed ID: 30234855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of intraocular pressure elevation following intravitreal injections].
    Budzinskaya MV; Shelankova AV; Andreeva YS
    Vestn Oftalmol; 2022; 138(5. Vyp. 2):240-246. PubMed ID: 36287162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)].
    Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
    J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.
    Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
    Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
    Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma.
    Agard E; Elchehab H; Ract-Madoux G; Russo A; Lagenaite C; Dot C
    Can J Ophthalmol; 2015 Apr; 50(2):127-31. PubMed ID: 25863852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections.
    Skalicky SE; Ho I; Agar A; Bank A
    Ophthalmic Surg Lasers Imaging; 2012 Jul; 43(4):328-34. PubMed ID: 22788585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current intravitreal therapy and ocular hypertension: A review.
    Sudhalkar A; Bilgic A; Vasavada S; Kodjikian L; Mathis T; de Ribot FM; Papakostas T; Vasavada V; Vasavada V; Srivastava S; Bhojwani D; Ghia P; Sudhalkar A
    Indian J Ophthalmol; 2021 Feb; 69(2):236-243. PubMed ID: 33463565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural changes in the ocular anterior segment against elevation of intraocular pressure after repeated intravitreal injections].
    Budzinskaya MV; Bubnova IA; Kurguzova AG; Fettser EI
    Vestn Oftalmol; 2018; 134(5. Vyp. 2):156-161. PubMed ID: 30499511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
    Dedania VS; Bakri SJ
    Retina; 2015 May; 35(5):841-58. PubMed ID: 25905784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
    J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents.
    Abedi G; Adelman RA; Salim S
    Semin Ophthalmol; 2013 May; 28(3):126-30. PubMed ID: 23631423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
    Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.
    Choi DY; Ortube MC; McCannel CA; Sarraf D; Hubschman JP; McCannel TA; Gorin MB
    Retina; 2011 Jun; 31(6):1028-35. PubMed ID: 21836409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
    Bressler SB; Almukhtar T; Bhorade A; Bressler NM; Glassman AR; Huang SS; Jampol LM; Kim JE; Melia M;
    JAMA Ophthalmol; 2015 May; 133(5):589-97. PubMed ID: 25719991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness.
    Omay E; Elgin U; Sen E; Yilmazbas P
    Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.
    Bracha P; Moore NA; Ciulla TA; WuDunn D; Cantor LB
    Surv Ophthalmol; 2018; 63(3):281-295. PubMed ID: 28882597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.